Funding

Spot Biosystems

United States · Biotech · Healthtech

Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines

Visit spotbiosystems.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$40MAdvantech Capital — Role not disclosedIDG Capital — Role not disclosedLDV Partners — Role not disclosedSaltagen Ventures — Role not disclosedShanda Ventures — Role not disclosedthe Stanford StartX fund — Role not disclosedTiger Jade Capital — Role not disclosed

Investors

Advantech CapitalSeries BIDG CapitalSeries BLDV PartnersSeries BSaltagen VenturesSeries BShanda VenturesSeries Bthe Stanford StartX fundSeries BTiger Jade CapitalSeries B

Coverage

Jun 17, 2026Spot Biosystems · Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesspotbiosystems.com ↗